Printer Friendly
The Free Library
14,679,069 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CHEMEQ RESEARCH TARGETS GLOBAL HUMAN PHARMACEUTICAL MARKETS.


Pharmaceutical company Chemeq Ltd [ASX ASX

See: Australian Stock Exchange
: CMQ CMQ Collège des Médecins du Québec
CMQ Conseil Médical du Québec
CMQ Centimetri Quadrati (Italian: Square Centimetres)
CMQ Club de Minéralogie de Québec (Canada)
CMQ Continuous Monitoring Query
CMQ Canonical Meta Query
], developer of the veterinary drug CHEMEQ (RTM (1) (RealTime Model) Refers to a system or architecture that performs operations in real time. See real time.

(2) (Release/Released To M
) polymeric antimicrobial, has begun a research program aimed at taking the company into global human pharmaceutical markets.

In one thrust of this research, Chemeq is collaborating with the world's leading research-investigator of Helicobacter pylori Helicobacter pylori
A gramnegative rod-shaped bacterium that lives in the tissues of the stomach and causes inflammation of the stomach lining.

Mentioned in: Indigestion, Ulcers

Helicobacter pylori
 infection in humans, Professor Barry Marshall, Burnet burnet, hardy perennial herb of the family Rosaceae (rose) found in temperate regions, usually with white or greenish flowers. The European species are sometimes cultivated for the leaves, which are used in salads, for flavoring, and formerly as a poultice to stop  Fellow at the University of Western Australia.

Helicobacter pylori infects more than half the human population of the world. While infection is often without symptoms, the organism is responsible for chronic gastritis, and most gastric and duodenal ulcers (excluding ulcers related to the use of non-steroidal antibiotic-inflammatory drugs). Additionally, the germ is a major factor in the onset of gastric adenocarcinoma adenocarcinoma: see neoplasm. , one of the most common forms of all cancers.

This collaboration has been consummated by an agreement between Chemeq Ltd and the University of Western Australia, the terms of which stipulate that all intellectual properties and rights (including commercial) remain with Chemeq.

Professor Marshall is world famous for his work with Dr Robin Warren in isolating and then establishing the association between H pylori H pylori Helicobacter pylori, see there , gastritis and peptic ulceration.

"To date, a number of times, we have noticed that CHEMEQ (RTM) polymeric antimicrobial has killed related Helico species in pigs," said Dr Graham Melrose, chairman and chief executive director of Chemeq. "Now Professor Marshall as well as our own laboratories have demonstrated the antimicrobial's activity against H pylori in laboratory test tubes. In the next phase, Professor Marshall is now assessing activity, in vivo, in mice."

CHEMEQ (RTM) polymeric antimicrobial is an alternative to the use of human antibiotics in animals. Chemeq Ltd is currently constructing commercial-scale manufacturing facilities for its veterinary drug, with production scheduled to begin the first half of 2003.

For more information, visit http://www.chemeq.com.au.
COPYRIGHT 2003 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Geographic Code:8AUST
Date:Jan 1, 2003
Words:296
Previous Article:RCT TISSUE-SPECIFIC HUMAN GENE PROMOTER PATENTED IN EUROPE.
Next Article:ORQIS MEDICAL BEGINS EUROPEAN CLINICAL TRIAL FOR CRS SYSTEM.
Topics:



Related Articles
Sumitomo Pharmaceuticals Subscribes to Gene Logic's GeneExpress Database.
MAP OF WW PROTEIN DOMAIN HELPS TARGET HEALTH PROBLEMS.(Company Business and Marketing)
MDS PROTEOMICS & ABGENIX DEVELOP ANTIBODY THERAPIES.
Daiichi Pharmaceuticals Subscribes to Gene Logic's BioExpress.
GENEFORMATICS/DE NOVO FORM DRUG DISCOVERY COLLABORATION.
CHEMEQ DEVELOPS POLYMER-BASED SUNSCREEN AND SKIN EMOLLIENT.
CHEMEQ DRUG ACTIVE AGAINST GASTRIC ULCER GERM.
Locus Pharmaceuticals Initiates Research Collaboration with Dow AgroSciences LLC.
ASTELLAS' SCREENING TRIGGERS MILESTONE PAYMENT TO METABOLEX.
Takeda Announces Positive Opinion from European Regulatory Authorities for Combination Use of Actos(R) with Insulin for Type 2 Diabetes.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles